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Kaplan and Brown (1)  first demonstrated that fractionated doses of x irradiation 
can cause leukemia. Gross (2) and Lieberman and Kaplan (3) subsequently reported 
the infectious transfer of neoplasia by radiation-induced leukemia virus  (RadLV) 1 
obtained from radiation-induced leukemias. Despite the identification of type C RNA 
particles in radiation-induced lymphomas and the demonstrations that such particles 
can, when injected into young mice, cause lymphomas (4), several investigators have 
challenged the concept of a  viral etiology for radiation-induced leukemia. Ihle et al. 
(5, 6)  and Haran-Ghera (7), for example, have argued for a  nonviral etiology for x 
irradiation-induced leukemia, primarily because, distinguished from the spontaneous 
AKR-  or  RadLV-induced  leukemias,  the  expression  of viral  antigens  cannot  be 
demonstrated in x ray-induced lymphomas by either immunofluorescence or radioim- 
mune competition assay. In addition, irradiation induces leukemia in mice, such as 
NIH Swiss and C57L, which have been shown to lack an integrated ecotropic murine 
leukemia virus (MuLV) genome (5, 6). 
However,  the  arguments  in  favor  of a  nonviral  etiology for  radiation-induced 
leukemia have been countered by the hypothesis of Dbcleve et al.  (8)  that RadLV 
may be initially activated in a replication-defective form (RadLV-O)  in which only 
the oncogenic segment, leuk, of the RadLV genome is expressed, and that RadLV 
acquires infectivity in vivo secondarily, possibly by a  recombination mechanism (in 
fact serological and structural analyses of RadLV indicate that this virus is probably 
a  recombinant  MuLV)  (9,  10). Recently,  Lieberman  et  al.  (11)  have  partially 
validated this concept with their finding that a leukemogenic virus may be obtained 
from nonproducer lymphoma ceils by "rescue"-type experiments involving infection 
with a nononcogenic virus. 
One approach that might shed light on the question of a viral etiology for radiation- 
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induced leukemia involves defining, localizing, and understanding the mode of action 
of genes involving in susceptibility to the radiation-induced disease. In this report, we 
define the genetics of susceptibility to radiation-induced  leukemia in  (A/J ×  B10)F2 
mice and localize the genes involved to chromosomes 1, 2, and 4. The loci involved in 
chromosomes 1 and 4 are close to or similar to the xenotropic virus inducibility locus 
on the chromosome (Bxv-1)  (12)  and xenotropic MuLV envelope-related cell-surface 
antigens  (XenCSA)  (13),  loci  previously  shown  to  determine  xenotropic  virus 
(xMuLV) inducibility and code for xMuLV gp70 determinants,  respectively. A  locus 
on chromosome 2  has  an overriding  influence  in susceptibility  to the  disease.  This 
locus may encode ecotropic viral-associated genetic information. 
Materials  and Methods 
Mice.  All mice were bred in our colony at the New York University Medical Center, N. Y. 
Antisera.  All alloantisera  were produced by immunizing recipient  mice with  spleen  and 
lymph node suspensions (1 donor/15 recipients)  on days 0, 21, 28, 35, and 42. Animals were 
bled on day 49. Thereafter, mice were boosted every 3rd wk, bled 7 and  10 d later, and their 
serum pooled. Antiserum to Ly-11.2 was raised by immunizing (A.AL X BALB.B)F1 mice with 
cells from B10.A(4R) mice. Anti-Ly-15.2 was obtained from (B10.A[4R] ×  B10.H'I'T)F1 mice 
immunized with A.AL cells. Monoclonal anti-Ly-6.2 (C3H/An anti-C57BL/6-H-2  k) was kindly 
provided by Dr. U. Hammerling, Sloan Kettering Institute, New York. Rabbit anti-mouse y2a 
(monospecific) was purchased from Litton Bionetics, Bethesda, Md. This reagent was required 
as a second step antibody before the protein A step (see below) for peripheral blood typing of 
mice for their Ly-6.2 phenotype. Monoclonal ),2a antibody (A/J anti-Bl0.A) to newly defined 
antigen  120 (14) was prepared in our laboratory by Dr. Janis Kennard. Alloantisera Ly-11.2 
[(BALB/c ×  SWR)F1 anti-B10-D2] was kindly provided by Dr. John G.  Ray, Jr.,  Research 
Resources Branch, National Institutes of Health, Bethesda, Md. 
Cell-binding Radioirnmunoassay.  This assay was performed  to measure  Ly-ll.2,  Ly-6.2,  120 
antigen, Ly-15.2, and H-2  a or H-2  b. Antigen-positive cells were measured by indirect radioim- 
munoassay using l~I-labeled protein A, as previously described (15). Briefly, 1 ×  106 to 5 ×  106 
cells were incubated with 50 #1 of  an appropriate serum dilution for 30 min at room temperature. 
The cells were diluted in 1 ml of phosphate-buffered saline (PBS)  plus 5% fetal calf serum (or 
1% bovine serum albumin [BSA]), centrifuged, and resuspended in 50 #1 of 1:100 dilution of 
12hi-labeled (2.5 ng) protein A (specific activity, 1,280 Ci/mmol or ~10  s cpm). After 30 min at 
room temperature, the samples were washed three times, and the cell pellets were transferred 
to a new tube and counted in a Beckman gamma counter 4000 (Beckman Instruments Inc., 
Fullerton, Calif.). 
Virus Susceptibility -Test.  Mice were scored as being either susceptible or resistant  at Fv-2, 
according to the results of spleen palpation on days 9 and 16 after receiving NB tropic  a Friend 
virus intravenously. 
Isoenzyme Assays.  Peripheral blood was collected from the retroorbital cavity of mice on PBS 
containing 100 U heparin/ml. Cells were washed three times and lysed by freezing and thawing 
in distilled water. Samples were kept frozen at -70°C until needed. Pep-3 (formerly Dip-l, EC 
3.4.11)  was assayed in starch gels as described by Nichols and Ruddle  (16).  Hemoglobin fl- 
chain was assayed by a modification of the methods of Hutton (17) and Eicker and Coleman 
(18). Basically, 30 ~1 of erythroeyte lysate plus 20/~1 of recrystallized iodoacetic acid (15.38 mg/ 
ml in 0.2 M  sodium phosphate buffer, pH 7.0) were incubated at room temperature for 2 h. 
The treated samples were then applied to cellulose acetate strips and electrophoresed at 300 V 
for 30 min in a Beckman Microzone apparatus, using a 25:3 ratio of distilled water:Tris-EDTA- 
borate buffer  (109:7.45:30.9 g/liter  of distilled  water,  pH 8.6).  Results  were scored without 
staining. 
Leukemogenic-fractionated Irradiation.  4- to 5-wk-old mice were irradiated unanesthetized using 
a  Cesium-137 source  (model M  Gammator,  Radiation Machinery Corp., Parsippany,  N. J.) 
with 180 rad weekly for 4 wk. 
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Results 
Susceptibili~/ Resistance to Radiation-induced Leukemia Is Coded  for by Genes on Chromosomes 
1,  2,  and  4.  As  shown  in  Fig.  1,  B10  (C57BL/10  ScSn)  mice  were  much  more 
susceptible to leukemia induction by four split doses of radiation (180 rad at weekly 
intervals)  than are A/J mice.  (A/J  x  B10)F1 mice show susceptibility intermediate 
between that of A/J and B10 strains. The mortality curves shown can be separated 
into two components: latency and final incidence. B10 mice display shorter latency 
and higher mortality than A/J mice. (A/J x  B10)FI mice display the high mortality 
associated with the B10 strain but also the longer latency of the A/J strain. 
An examination of 11 traits coded for by loci on six murine chromosomes in (A/J 
x  B 10)F2 mice shows genetic effects linked to chromosomes 1 (Pep-3), 2 (Ly-11, Ly-6), 
and 4  (b, Gpd-1,  Ly-15.2) (Table I). Although females seemed to be more susceptible 
to leukemia induction by fractionated irradiation (FXI), the difference has not been 
found to be statistically significant. 
A  Major Locus  Conferring Resistance  to FXI Induction of Leukemia  Maps in  Chromosome 
2.  We have previously (D. Meruelo, unpublished data)  mapped loci coding for cell 
surface alloantigens Ly-6 and Ly-11 to chromosome 2. The map order is (centromere 
at left)  (Ly-4--Ly-6)--Ly-ll--H-13--a.  As can be seen from Table II, susceptibility 
to FXI is very predictable on the basis of Ly-6 or Ly- 11 phenotype. The A/J parental 
phenotype, Ly-6.1. Ly-11.1, is associated with resistance, the association being slightly 
stronger with Ly-6.1 than with Ly-11.1 (9 and  15% leukemia incidence, respectively). 
The leukemia incidence in  (A/J  ×  B10)F2 mice bearing the Ly-6.1 and/or Ly-11.1 
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Fro.  1.  Susceptibility  of BI0, A/J, and (A/J x BI0)F] mice to leukemia induction by four doses 
of 17.5 rad given at weekly  intervals. Incidences  in 1.5 B10, 39 Fh and 23 A/J mice were examined 
in one experiment.  In another experiment, 120 A/J mice were studied. 1204  GENETICS OF SUSCEPTIBILITY TO  RADIATION-INDUCED LEUKEMIA 
TABLE  I 
Linkage or Lack of Linkage of Genes Coding  for Resistance to Radiation-induced Leukemia 
with  Traits Found on Six Different Murine Chromosomes in 
(A/J ×  BIO)F1  ×  (A/J ×  BIO)FI Offspring 
Chromosome  Linkage  Trait tested  Reference  location  found 
Pep-C  1  (19)  Yes 
Ly-11, Ly-6  2  (Meruelo et al., unpublished data)  Yes 
b, Ly-15.2R  4  b(20), Ly-15.2 (21)  Yes 
c, Hbb, 120  7  c(20), Hbb (17), 120 (14)  No 
Fvo2  9  (22)  No 
H-2  17  (23)  No 
TABLE  II 
A Gene Closely Linked to Those Coding  for Ly-ll.2 and Ly-6.2 on Chromosome 2 Is 
Primarily Responsible  for Resistance or Susceptibility to Radiation-induced Leukemia 
Phenotype*  Leukemia in- 
Number  cidence on 
(A/J × B 10)F2 or progenitor strain  of mice  day 250 after 
Ly- 11  Ly-6  FXI 
% 
A/J  23  11.1/11.1  6.1/6.1  4 
A/J  120  11.1/11.1  6.1/6.1  17 
B10  15  11.2/11.2  6.2/6.2  88 
(A/J × B10)F1  39  11.1/11.2  6.1/6.2  64 
39  11.l/11.1  15 
[(A/J × BI0)Fx ×  105  11.1/11.2  65 
(A/J × BIO)F,]  49  11.2/11.2  86 
45  6.1/6.1  9 
[(A/J × B10)Fx ×  97  6.1/6.2  70 
(a/J × B10)F1]  51  6.2/6.2  90 
* It should be noted that phenotypes were only determined with antisera to Ly-11.2 and Ly- 
6.2 alleles because neither anti-Ly-I  1.1 nor anti-Ly-6.1 were available. However, because 
gene dosage quantitatively determines  expression of these antigens,  no difficulties were 
encountered in distinguishing homozygous from heterozygous phenotypes. 
phenotype  is not  different  from  the  disease incidence  in  A/J  mice,  which  strongly 
suggests that  in this intercross other genes play a  secondary role in susceptibility to 
the  disease.  As  would  be  expected,  the  Ly-6.2  and/or  Ly-ll.2  phenotypes  are 
associated with  the  high  leukemia  incidence of the  parental  B10  (Ly-6.2,  Ly-11.2) 
strain.  The  incidence of leukemia is similar in  (A/J  ×  B10)Fa  and  (A/J  ×  B10)F2 
mice displaying the heterozygous phenotype at either Ly-6 or Ly- 11. 
An analysis of recombination frequencies between the genes coding for susceptibility 
locus (radiation-induced leukemia-l, RiLl)  and Ly-6 and  Ly-11  (Table III) suggests 
that  the gene order on  chromosome  2  is Ril-l--Ly-6--Ly-ll.  The exact  location of 
RiLl  with respect to the genes coding Ly-4 and minor histocompatibility locus H-3 
(Fig. 2) cannot be ascertained at present because although typing sera for Ly-4.2 are 
available, there are none for Ly-4.1 or H-3. Although Ly-6.1 and Ly-6.2 as well as Ly- DANIEL MERUELO, MIRIAM OFFER, AND NANEq"TE FLIEGER  1205 
TABLE III 
Determination of Recombination Frequency between Leukemia Susceptibility (Ril-1) and Ly-11 and Ly-6 in 
(.4/.] x  BIO)Fz, F2 Offspring 
Phenotypic  class  Phenotypic  class*  Phenotypic  class*  Percentage  re-  X  2 of 
combination*  associ- 
l,y-6  Ril-l*  Scor~  nil  ns¶  Ly-ll  Ril-l:~  Score§  nil  ns¶  Ly-ll  Ly-6  Score~  nil  ns¶  mSEV:~*  ation§§ 
6.2/6.2  gs  -4/3  46  -61.33  I 1.2/11.2  ss  -4/3  42  -56  11.2/11.2  6.2/6.2  -4  45  -180  l,y-6--Ril-I  X  2 =  77.67 
B0.11 ±0.02 
6.2/6.2  rr  4  5  20  11.2/11.2  rr  4  7  28  11.2/11.2  6.1/6.1  4  2  8  Ly-ll--gil-1  X~ffi44.86 
=0,20±0.04 
6.1/6.1  ss  4/3  4  5.33  11.1/11.1  ss  4/3  6  8  I1.1/11.1  6.2/6.2  4  2  8  Ly-ll--Ly-6  X~I  122.88 
=0.10±0.02 
6.1/6.1  rr  --4  41  r-164  11.I/11.1  rr  --4  33  --132  11.1/11.1  6.1/6.1  --4  36  -144 
i 
193  193  193 
* Only the relevant  phenotypic  classes used in calculating  recombination  frequencies according  to M. Green  (25) are shown. 
* r, resistant; s, susceptible. 
§ Scores of maximum likelihood  when two traits are co-dominant (semidominant)  and an intercross is being examined (25). 
[[ n ffi number of F2 offspring in that phenotypic  class. 
¶  ns =  n  ×  score for a  given phenotypic  class. 
D 
** Recombination  frequency computed according  to the formula  (25) P -- 0.5 +  ~'  where D ffi ~  ns and Ip -  4 n for Ly-11--Ly-6 and Ip ffi (8/3)n for 
Ly-6--Ril-I  and Ly-I 1--Ril-l.  lp 
:]:~ se =  dr(I  +  2r)  (I +  6r) ~ 4n (26), where r is the recombination  frequency and se is the standard error. 
§~fl -  I)~  where D  =  5": ns and Ip =  4n, as in footnote  6. 
""  Ip' 
H-3  ~y-6)  Ly-li  H-13  A 
• -//  I  I  I  I  I 
Ly -4 
P2-microglobulin 
Fro.  2.  Location  of Ril-l,  a  locus  coding  for  susceptibility  to  radiation-induced  leukemogenesis. 
The  data  on  Table  III  suggest  that  RiLl  is  to  the  left  (centromeric  end)  of  the  gene  coding  for 
Ly-6,  but  the standard  deviation  makes  precise  location  tenuous. 
11.1  and Ly-11.2 show codominant expression, allowing identification of the hetero- 
zygous phenotype with a single reagent for either allele, the heterozygous phenotype 
for Ly-4  is not distinguishable  from  the homozygous Ly-4.2  with just  one reagent. 
Currently,  H-3  typing  can  only  be  clone  by  allograft  transplantation,  and  this 
approach is not suitable in (A/J ×  B 10)F2 mice in which other histocompatibility loci 
are segregating simultaneously. 
Loci Next to XenCSA on Chromosome 4 and Pep-3 on Chromosome 1 Influence Susceptibility 
to FXI-induced Leukemia.  We have shown elsewhere  (21) that a locus on chromosome 
4, defined as Ly 15.2R, is one of two genes that affects the expression ofa T lymphocyte 
surface  determinant,  Ly-15.2,  which  was  previously  undefined.  The  gene  order 
(centromere at left)  is Ly-b4--b--Ly-15.2R--XenCSA--Fv-1.  XenCSA are antigenic 
determinants related to the major glyeoproteins (gp  70) of xMuLV  (26). Ly-15.2R is 
1-3% recombination units away from the locus affecting XenCSA expression and has 
been shown to be distinct by several criteria, including recombination  (21). 
When leukemia incidence in (A/J ×  B10)F2 mice is examined,  it can be seen that 
Ly-15 phenotype is a good predictor of relative survival  (Table IV). Mice that carry 1206  GENETICS  OF  SUSCEPTIBILITY  TO  RADIATION-INDUCED  LEUKEMIA 
TABLE  IV 
A  Gene Closely Lblked to Ly-15.2R*  on Chromosome 4 Is Involved in Greater 
or Lesser Resistance to Radiation-induced  Leukemia  in  (A/J  ×  B I O) F2 Mice 
Number of mice tested  Percentage of phe- 
Ly- 15  notype:]: nonleu- 
phenotype  Alive  Leukemia  Total  kemic 300 d  after 
last FXI 
% 
15.1/15.1  26  19  45  58 
15.1/15.2  23  21  44  52 
15.2/15.2  6  15  21  29 
* A/Js Ly-15 genotype is 15.2/15.2, whereas B10s Ly-15 genotype is 15.1/15.1. 
~: It should be stressed that the observed phenotypic ratio is not different from 
that expected for a  trait whose expression is under two gene control (regulator 
and structural loci), which is the case for Ly-15.2 (21). The results obtained do 
not result from phenotyping difficulties because none was encountered. If Ly- 
15 expression were under single gene control the expected ratios for 15.1/15.1, 
15.1/15.2,  and  15.2/15.2 would be 0.25, 0.50, and 0.25, respectively. On the 
other  hand,  two-gene control  for  Ly-15 expression would  lead  to  ratios  of 
0.4375,  0.375,  and  0.1875,  which  are  not  significantly different  from  those 
obtained (X  2 ~  0.98). 
TASLE  V 
A  Gene Closely Linked to Pep-3*  on Chromosome 1 Is Involved in Greater or 
Lesser Resistance to Radiation-induced  Leukemia  in  (A/J  ×  B I O) F2 Mice 
Number of mice tested  Percentage pheno- 
Pep-C  type nonleukemic 
phenotype  Alive  Leukemic  Total  300 days after last 
FXI 
% 
BB  19  27  46  41 
AB  38  61  99  38 
AA  7  41  48  15 
* A/Js Pep-3 genotype is AA; B10s Pep-3 genotype is BB. 
the B10 parental genotype or are heterozygous have a  higher relative survival  than 
those hornozygous for the parental A/J allele. 
Pep-3  is  an  isoenzyme  coded  for  by  chromsome  1.  When  (A/J  ×  B10)F2  mice 
classified  by  peptidase  3  allele  by  isoenzyme  analysis  are  compared  for  leukemia 
incidence,  mice  having  the  B10  allele  (homozygous or  heterozygous)  show  greater 
survival than those having the A/J peptidase allele (Table V). Thus, data on Tables 
IV and V  indicate that susceptibility to FXI-induced leukemia is influenced by genes 
on chromosomes  1 and 4. These genes shall be defined as Ril-2 and Ril-3, respectively. 
Discussion 
Current  investigations  into  murine  leukemogenesis  have  focused  on  the  role  of 
naturally occurring recombinant  type C  viruses  in the disease  process.  Most mouse 
strains carry endogenous ecotropic and xenotropic virus information in their genomes 
and transmit these as if they were Mendelian traits (27). 
Two  observations  have  suggested  that  the generation  of recombinant  polytropic DANIEL MERUELO, MIRIAM OFFER, AND NANETTE FLIEGER  1207 
virus from host  ecotropic and xenotropic information is of critical importance for, 
and precedes, malignancy. First, polytropic virus appearance in AKR mice correlates 
well with  the development of spontaneous leukemia  (28,  29).  Second, infection of 
recombinant  polytropic virus  (but  no  ecotropic or xenotropic viruses)  into young 
AKR mice markedly accelerates the onset of leukemia (30, 31). 
In view of the importance of recombinant viruses to leukemogenesis, it is of interest 
that  genes closely linked to loci coding for xenotropic inducibility (Bxv-I  [12])  and 
affecting expression of xenotropic virus structural components (XenCSA [ 13]) influ- 
ence resistance to FXI-induced neoplasia. It is possible that xenotropic and ecotropic 
virus  recombination would  be one of several  events  triggered  by the  fractionated 
irradiation protocol. This expectation is strengthened by the fact that leukemogenic 
viruses isolated from radiation-induced thymomas have shown to be recombinants. 
Therefore, the finding that xenotropic virus loci or adjacent genes might influence the 
disease outcome should not be surprising. An extension of this postulate would suggest 
that  ecotropic virus sequences would also be involved in leukemogenesis. RiLl, the 
chromosome 2  locus, might be thought of in this context. This is  not  improbable, 
considering that determinants coded for by the nearby Ly-6 locus are present on AKR 
virus (32). We shall return to the RiLl locus shortly, but a few additional comments 
on Ril-2 and Ril-3 are in order. 
First, it is clear that the linkage of Ril-2 and Ril-3 to Bxv-I and XenCSA is presently 
only suggested. Precise mapping by three-point genetic testing is required to ascertain 
the exact mapping location and possible coincident mapping of  these loci. Nonetheless, 
preliminary data, not reported here, strongly suggest that Bxv-1 and XenCSA or very 
closely linked genes are indeed reponsible for susceptibility to FXI-induced leukemo- 
genesis. 
Second, it is particularly interesting that A/J-derived alleles of loci on chromosomes 
1 and 4 promote leukemia more effectively than the B10-derived alleles of these loci. 
This finding was unexpected because B 10 mice are more susceptible than A/J to the 
leukemogenic effects of FXI.  This  is,  however,  concordant  at  least  for  the  locus 
affecting XenCSA expression because levels of XenCSA are high in A/J and low in 
B10  mice  (24).  Although  xenotropic virus can be induced by 5-iododeoxyurindine 
treatment from B10 cells, no induction is possible from A/J cells (12). It is not easy to 
reconcile this finding with the notion that Bxv-1 is important in susceptibility to FXI- 
induced  leukemia.  Nonetheless, A/J  mice  are  positive for spontaneous  xenotropic 
virus expression assayed by immunoflureseenee or focus formation (33), and, as just 
stated, they express high levels of some structural components (e.g., XenCSA). The 
linkage to Bxv-1 might not have to do with xenotropic virus inducibility but rather 
with the frequency or efficiency of recombinational events controlled by a gene linked 
to Bxv-1, and the genotype of A/J at this locus might promote recombination more 
frequently or efficiently than that of B 10. Without additional data on the chromosome 
1 locus, it is futile to speculate further at the moment, but this issue must be resolved 
before its mode of action can be understood. 
Third, it is clear that recombinant viruses are not always obtained from radiation- 
induced tumors, and as stated in the Introduction, the role for viruses in the disease 
is  not  clear.  This  is  consistent  with  the  fact  that  Ril-1  is  the  predominant  locus 
affecting leukemogenesis. Ril-2 and Ril-3 play secondary roles, suggesting that, indeed, 
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transformation. If the explanation of FXI-induced neoplasia by Decl~ve et al.  (8)  is 
accepted,  however,  one  must  conclude  that  at  least  activation  of cellular  DNA 
sequence  with  oncogenic  potential  is  necessary  for  malignancy  even  when  virus 
involvement cannot be demonstrated. In this context, it is provocative to ask whether 
RiLl is involved in oncogene activation or represents a  MuLV-associated oncogenic 
sequence or cellular oncogene. 
It is intriguing that RiLl is located in a  chromosomal site rich in differentiation- 
specific loci (i.e., loci coding for H-3, H-13, H-30, Ly-6, Ly-8, Ly-ll, ThB, H9/25, 
etc.)  (Meruelo  et  al.,  unpublished  data).  It  has  been  postulated  that  the  site  of 
integration of viruses is important for their expression. For example, mammary tumor 
virus expression is found in mammary gland cells but not in cells of spleen, thymus, 
or  other  organs  (34).  An  explanation  for  tissue-specific  activation  of endogenous 
viruses would be that one set of integration sites of a  virus may be compatible with 
virus genome expression in a  given cell, whereas virus genomes integrated at  other 
sites may be silent (35). 
Radiation-induced leukemia appears  to require an abundance of immature lym- 
phoblastic cells that are present in the periphery of the thymic cortex during the first 
2 wk of life and decrease sharply in number thereafter (36, 37). After irradiation, the 
thymus has been shown  to undergo injury characterized by profound depletion of 
lymphoid cells followed by a  period of regeneration, during which the same type of 
immature lymphoblastic cells are once again present for a period of several days (38). 
This short period of lymphoblastic cell regeneration may be critical for the restoration 
of thymus susceptibility to leukemogenesis in irradiated animals (38). We have shown 
elsewhere (39) that Ly- 11.2 cells, which include prothymocytes, increase substantially 
in number for a short period of time past FXI in animals susceptible to the induction 
of leukemia and again during the preleukemic period. Thus, the linkage of RiLl and 
Ly-ll  would  suggest  that  this  region of chromosome is  not  silent  to  the  inductive 
effects of FXI. 
A clarifying note should be made before closing. Recently, Horton and Heterington 
(40)  demonstrated linkage of Ly-6 and  Thy-1 on chromosome 9.  Using monoclonal 
antibodies to Ly-6, Thy-1.1, and Thy-l.2 and strain crosses similar to those used by 
these  authors  [e.g.,  (B10  ×  A.Thy-l.1)Fz], we  have  been  unable  to  confirm  their 
findings despite extensive efforts to do so. Our findings, as reported here, indicate that 
Ly-6 is on chromosome 2, although exact distances between the locus and Ly-4 and 
agouti remain for now tentative. We are engaged in more extensive analyses of other 
chromosome 2 markers  for greater precision in  locating this locus within the chro- 
mosome. 
Summary 
Susceptibility to radiation-induced leukemia in (A/J x  B 10)Fz mice is encoded for 
by genes in chromosomes 1, 2, and 4. The loci involved in chromosomes 1 and 4 are 
close to or similar to xenotropic virus inducibility locus on chromosome 1 and a locus- 
affecting  expression  of xenotropic  MuLV  envelope-related  cell  surface  antigens. 
Radiation-induced leukemia-1 (Ril-l) on chromosome 2 plays an overriding influence 
in  susceptibility to the  disease.  This  locus  might  encode ecotropic viral-associated 
genetic  information or might  contain  cellular sequences with  oncogenic potential. 
These findings are of interest  in  view of the  importance of recombinant  viruses to DANIEL  MERUELO, MIRIAM OFFER,  AND NANETTE FLIEGER  1209 
leukemogenesis.  Furthermore,  it is intriguing that Ril-1  is located in a  chromosomal 
site  rich  in  thymus  differentiation-specific  loci.  An  explanation  for  tissue-specific 
activation of endogenous viruses is that activation of the virus in question is dependent 
on differentiation-specific steps. 
Received  for publication 23 March 1981 and in revised  form 25June 1981. 
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